Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydrocortisone Treatment for Symmetric Lipomatosis Associated With Neuropathy (SLN): an N-of-1 Study

NCT04821583 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT04821583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04821583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydrocortisone Treatment for Symmetric Lipomatosis Associated With Neuropathy (SLN): an N-of-1 Study
Lead sponsor
Erasmus Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
June 1, 2021
Completion date
September 1, 2022
Enrollment
1 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

symmetric lipomatoses, multiple